Clinical trial

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

NCT07312110

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention D-serine Find medicine records · Find other trials using this name

DIETARY_SUPPLEMENT · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-20

PhasePHASE2

Conditions

Parkinson s Diseaseunresolved

Parkinson Disease (PD)unresolved

Interventions

D-serineDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Haukeland University Hospitallead sponsor

SPARK NScollaborator

University of Bergencollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07312110 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.